RW effectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment (TRACE)


Por: Serra-Baldrich, E, Armstrong, AW, Festini, T, Ivens, U, Nielsen, IV, Wiseman, M, Krüger-Szabo, A

Publicada: 1 abr 2025
Resumen:


Filiaciones:
Serra-Baldrich, E:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Dermatol, Barcelona, Spain

Armstrong, AW:
 Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA

Festini, T:
 LEO Pharm, Ballerup, Denmark

Ivens, U:
 LEO Pharm, Ballerup, Denmark

Nielsen, IV:
 LEO Pharm, Ballerup, Denmark

Wiseman, M:
 SKiNWISE Dermatol, Winnipeg, MB, Canada

Krüger-Szabo, A:
 LEO Pharm GmbH, Neu Isenburg, Germany
ISSN: 16100379





JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Alemania
Tipo de documento: Meeting Abstract
Volumen: 23 Número:
Páginas:
WOS Id: 001515598600304

MÉTRICAS